Cisen Pharmaceutical (603367) Stock Overview
Research, develops, produces, and sells drug products in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 603367 from our risk checks.
603367 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Cisen Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.42 |
| 52 Week High | CN¥16.13 |
| 52 Week Low | CN¥11.70 |
| Beta | 0.31 |
| 1 Month Change | 3.56% |
| 3 Month Change | 15.33% |
| 1 Year Change | 10.46% |
| 3 Year Change | 31.57% |
| 5 Year Change | -11.94% |
| Change since IPO | -8.16% |
Recent News & Updates
Shareholder Returns
| 603367 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 8.3% | 2.2% | 0.4% |
| 1Y | 10.5% | 25.2% | 26.0% |
Return vs Industry: 603367 underperformed the CN Pharmaceuticals industry which returned 25.2% over the past year.
Return vs Market: 603367 underperformed the CN Market which returned 26% over the past year.
Price Volatility
| 603367 volatility | |
|---|---|
| 603367 Average Weekly Movement | 4.2% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in CN Market | 8.8% |
| 10% least volatile stocks in CN Market | 3.1% |
Stable Share Price: 603367 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603367's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1970 | 3,302 | Zhenxin Du | www.cisen-pharma.com |
Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products in China and internationally. The company’s chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infective drugs, narcotic analgesics, obstetrics and gynecology medication, digestive system medication, respiratory system medication, immune system drugs, and hormonal drugs. It also offers Chinese medicine preparations; complete and incomplete nutritional formula food; specific nutritionally complete formula foods; nutritious food; health food; API; and packaging products.
Cisen Pharmaceutical Co., Ltd. Fundamentals Summary
| 603367 fundamental statistics | |
|---|---|
| Market cap | CN¥7.00b |
| Earnings (TTM) | CN¥489.59m |
| Revenue (TTM) | CN¥3.75b |
Is 603367 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603367 income statement (TTM) | |
|---|---|
| Revenue | CN¥3.75b |
| Cost of Revenue | CN¥1.75b |
| Gross Profit | CN¥2.00b |
| Other Expenses | CN¥1.51b |
| Earnings | CN¥489.59m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 28, 2025
| Earnings per share (EPS) | 1.08 |
| Gross Margin | 53.38% |
| Net Profit Margin | 13.05% |
| Debt/Equity Ratio | 0.2% |
How did 603367 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/08 09:06 |
| End of Day Share Price | 2025/07/08 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cisen Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiaxi Xu | Industrial Securities Co. Ltd. |